- Hauptnavigation
- Navigation des Hauptbereiches
- Inhalt der Seite
Navigation des Hauptbereiches
Publications
Selected Publications
Schaefer, M., Pollex, T., Hanna, K., Tuorto, F., Meusburger, M., Helm, M., and Lyko, F. (2010). RNA methylation by Dnmt2 protects transfer RNAs against stress-induced cleavage.
Grönniger, E., Weber, B., Heil, O., Peters, N., Stäb, F., Wenck, H., Korn, B., Winnefeld, M., and Lyko, F. (2010). Aging and chronic sun exposure cause distinct epigenetic changes in human skin.
Brueckner, B., Rius, M., Markelova, M.R., Fichtner, I., Hals, P.A., Sandvold, M.L., and Lyko, F. (2010). Delivery of azacytidine to human cancer cells by elaidic acid esterification increases therapeutic drug efficacy.
Brueckner, B., Stresemann, C., Kuner, R., Mund, C., Musch, T., Meister, M., Sultmann, H., and Lyko, F. (2007). The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res. 67, 1419-1423.
Stresemann, C., Brueckner, B., Musch, T., Stopper, H., and Lyko, F. (2006). Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res. 66, 2794-2800.
Mund, C., Hackanson, B., Stresemann, C., Lübbert, M., and Lyko, F. (2005). Characterization of DNA demethylation effects induced by 5-aza-2’-deoxycytidine in patients with myelodysplastic syndrome. Cancer Res. 65, 7086-7090.
Brueckner, B., Boy, R.G., Siedlecki, P., Musch, T., Kliem, H.C., Zielenkiewicz, P., Suhai, S., Wiessler, M., and Lyko, F. (2005). Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases.Cancer Res. 65, 6305-6311.
